A Study to Evaluate the Efficacy and Safety of Risperidone for the Prevention of Mood Episodes in the Treatment of Patients With Bipolar I Disorder

计划入组 585 人 · 首次发布于 2006 年 10 月 23 日

QL vs LAI for Palatoplasty

计划入组 46 人 · 首次发布于 2024 年 5 月 20 日

Olanzapine vs. Low-dose Olanzapine Plus Trifluoperazine

计划入组 94 人 · 首次发布于 2016 年 3 月 10 日

Olanzapine(Lybalvi, Olazax, Symbyax, Zalasta, Zypadhera, Zyprexa, Olanzapine Glenmark Europe, Olanzapine Apotex, Olanzapine Teva, Olazax Disperzi, Olanzapine Mylan, Zyprexa Velotab, Olanzapine Glenmark, Olanzapine Viatris (previously Olanzapine Mylan), Olansek, Olanzapine Cipla (previously Olanzapine Neopharma))

C₁₇H₂₀N₄S · Rx

Olanzapine/Zonisamide

Olanzapine pamoate(Zypadhera)

LAI CORPORATION PTY LTD

Australia

PKU HealthCare Corp., Ltd.

China

CTO Realty Growth

United States

Teva's Olanzapine LAI Shows Positive Phase 3 Results for Schizophrenia

Teva's Olanzapine LAI Shows No PDSS Events in 56-Week Phase 3 Trial, Paving Way for First Long-Acting Olanzapine Treatment

Olanzapine LAI Shows Promise in Schizophrenia Treatment with Improved Safety Profile